Research Topics
| Sean D SullivanSummaryAffiliation: University of Washington Country: USA Publications
| Collaborators
|
Detail Information
Publications
Cost-effectiveness of peginterferon alpha-2a compared to lamivudine treatment in patients with hepatitis B e antigen positive chronic hepatitis B in TaiwanSean D Sullivan
University of Washington, Seattle, Washington 98195, USA
J Gastroenterol Hepatol 22:1494-9. 2007....
An evaluation of the cost-effectiveness of omalizumab for the treatment of severe allergic asthmaS D Sullivan
Pharmaceutical Outcomes Research and Policy Program, University of Washington, Seattle, WA 98195, USA
Allergy 63:670-84. 2008..In patients who respond to therapy, the cost-effectiveness of omalizumab compares well with other biologic treatments for chronic illness...
Economic consequences of sequencing biologics in rheumatoid arthritis: a systematic reviewSean D Sullivan
Pharmaceutical Outcomes Research and Policy Program, School of Pharmacy, University of Washington, Seattle, WA 98195 7630, USA
J Med Econ 16:391-6. 2013..However, little is known about whether or not switching to anti-TNF or other non-TNF biologic treatments is cost-effective. This study sought to review the economic evidence of sequencing various biologic treatments in RA...
A multisite randomized trial of the effects of physician education and organizational change in chronic asthma care: cost-effectiveness analysis of the Pediatric Asthma Care Patient Outcomes Research Team II (PAC-PORT II)Sean D Sullivan
Pharmaceutical Outcomes Research and Policy Program and Department of Pediatrics, University of Washington, Seattle, WA 98195, USA
Arch Pediatr Adolesc Med 159:428-34. 2005....
Exploring new frontiers in asthma management for optimal therapeutic and economic outcomesSean D Sullivan
Pharmaceutical Outcomes Research and Policy Program, Department of Pharmacy, University of Washington, 1959 NE Pacific Ave, Box 357630, Seattle, WA 98195, USA
J Manag Care Pharm 9:2. 2003
Long-term outcomes in patients with type 2 diabetes receiving glimepiride combined with liraglutide or rosiglitazoneSean D Sullivan
Pharmaceutical, Outcomes Research and Policy Program, University of Washington, Seattle, USA
Cardiovasc Diabetol 8:12. 2009..Studies of new diabetes treatments are rarely designed to assess mortality, complication rates and costs. We sought to estimate the long-term consequences of liraglutide and rosiglitazone both added to glimepiride...
A cost-effectiveness analysis of fondaparinux sodium compared with enoxaparin sodium as prophylaxis against venous thromboembolism: use in patients undergoing major orthopaedic surgerySean D Sullivan
Department of Pharmacy and Health Services, University of Washington, Seattle, Washington 98195, USA
Pharmacoeconomics 22:605-20. 2004..To determine the cost effectiveness of fondaparinux sodium compared with enoxaparin sodium for prophylaxis against venous thromboembolism in patients undergoing major orthopaedic surgery...
Health state preference assessment in diabetic peripheral neuropathySean D Sullivan
Department of Pharmacy, University of Washington, Seattle, Washington 98195 7630, USA
Pharmacoeconomics 20:1079-89. 2002..To assess patient preferences for health states associated with diabetic peripheral neuropathy (DPN)...
Measuring the outcomes and pharmacoeconomic consequences of venous thromboembolism prophylaxis in major orthopaedic surgerySean D Sullivan
Pharmaceutical Outcomes Research and Policy Program, University of Washington, Seattle 98195 7630, USA
Pharmacoeconomics 21:477-96. 2003..These recommendations are based on extensive examination of recent advances in the management of VTE combined with a greater understanding of its natural history...
Cost effectiveness of peginterferon alpha-2a plus ribavirin versus interferon alpha-2b plus ribavirin as initial therapy for treatment-naive chronic hepatitis CSean D Sullivan
University of Washington, Seattle, Washington, USA
Pharmacoeconomics 22:257-65. 2004..The objective of this study was to determine if the gain in SVR with peginterferon alpha-2a plus ribavirin is worth the incremental cost...
A simulation of the comparative long-term effectiveness of liraglutide and glimepiride monotherapies in patients with type 2 diabetes mellitusSean D Sullivan
Pharmaceutical Outcomes Research and Policy Program, University of Washington, Seattle, WA 98195, USA
Pharmacotherapy 29:1280-8. 2009..To project and compare long-term outcomes of morbidity and mortality, and costs of complications of type 2 diabetes mellitus from a randomized controlled trial of patients receiving liraglutide versus glimepiride monotherapy...
Emerging therapeutic strategies for asthma managementSean D Sullivan
Pharmaceutical Outcomes Research and Policy Program, Department of Pharmacy, University of Washington, 1959 NE Pacific Ave, Box 357630, Seattle, WA 98195, USA
J Manag Care Pharm 9:14-21. 2003..The describe the mechanisms of action of and clinical experience to date with novel asthma drug therapies...
Asthma in the United States: recent trends and current statusSean D Sullivan
Pharmaceutical Outcomes Research and Policy Program, Department of Pharmacy, University of Washington, 1959 NE Pacific Ave, Box 357630, Seattle, WA 98195, USA
J Manag Care Pharm 9:3-7. 2003....
The promise of specialty pharmaceuticals: are they worth the price?Sean D Sullivan
Pharmaceutical Outcomes Research and Policy Program, University of Washington, Seattle, WA 98195 7630, USA
J Manag Care Pharm 14:S3-6. 2008..Due in part to the cost of these therapies, payers are increasingly demanding evidence of their value. Determining the value of these medications is hampered by a lack of robust pharmacoeconomic data...
Cost-effectiveness of fondaparinux compared with enoxaparin as prophylaxis against venous thromboembolism in patients undergoing hip fracture surgerySean D Sullivan
Pharmaceutical Outcomes Research and Policy Program, University of Washington, Seattle, WA 98195, USA
Value Health 9:68-76. 2006..To evaluate the cost-effectiveness of fondaparinux relative to enoxaparin as prophylaxis against venous thromboembolism (VTE) in patients undergoing hip fracture surgery...
Cost-effectiveness of risk stratification for preventing type 2 diabetes using a multi-marker diabetes risk scoreSean D Sullivan
University of Washington, Seattle, WA 98195 7630, USA
J Med Econ 14:609-16. 2011..The first approach identified high risk patients using impaired fasting glucose (IFG). The second approach used the PreDx Diabetes Risk Score (DRS) to further stratify IFG patients into high-risk and moderate-risk groups...
The economic burden of COPDS D Sullivan
Departments of Pharmacy and Health Services, University of Washington, Seattle, WA 98195, USA
Chest 117:5S-9S. 2000..These trends reflect population aging, smoking patterns, institutional factors, and treatment practices...
Study protocol: the Back Pain Outcomes using Longitudinal Data (BOLD) registryJeffrey G Jarvik
Department of Radiology, University of Washington, Seattle, WA, USA
BMC Musculoskelet Disord 13:64. 2012....
Cost-effectiveness of peginterferon alpha-2a compared with lamivudine treatment in patients with HBe-antigen-positive chronic hepatitis B in the United KingdomDavid L Veenstra
University of Washington, Seattle, Washington 98195, USA
Eur J Gastroenterol Hepatol 19:631-8. 2007..We assessed the clinical outcomes and costs, from the perspective of the UK National Health Service, of 48 weeks of peginterferon alpha-2a (40 kDa) vs. 4 years of lamivudine...
HBeAg-negative chronic hepatitis B: cost-effectiveness of peginterferon alfa-2a compared to lamivudine in TaiwanDavid L Veenstra
University of Washington, Seattle, WA, USA
Value Health 11:131-8. 2008..Our objective is to evaluate the incremental cost-effectiveness of 48 weeks of peginterferon alfa-2a compared to 48 weeks of lamivudine, from the perspective of the Taiwan Bureau of National Health Insurance...
A multisite randomized trial of the effects of physician education and organizational change in chronic-asthma care: health outcomes of the Pediatric Asthma Care Patient Outcomes Research Team II StudyPaula Lozano
Center for Health Studies, Group Health Cooperative, 1730 Minor Avenue, Seattle, WA 98101, USA
Arch Pediatr Adolesc Med 158:875-83. 2004..Traditional primary care practice change approaches have not led to full implementation of national asthma guidelines...
Study protocol- Lumbar Epidural steroid injections for Spinal Stenosis (LESS): a double-blind randomized controlled trial of epidural steroid injections for lumbar spinal stenosis among older adultsJanna L Friedly
Comparative Effectiveness, Cost and Outcomes Research Center, University of Washington, Seattle, USA
BMC Musculoskelet Disord 13:48. 2012....
Cost effectiveness of entecavir versus lamivudine with adefovir salvage in HBeAg-positive chronic hepatitis BDavid L Veenstra
Pharmaceutical Outcomes Research and Policy Program, Department of Pharmacy, University of Washington, Seattle, Washington 98195, USA
Pharmacoeconomics 25:963-77. 2007..Previous economic analyses have been limited by the lack of comparative clinical data for entecavir and lamivudine beyond 1-year duration and for salvage therapy...
An evaluation of the potential cost-effectiveness of non-invasive testing strategies in the diagnosis of significant liver fibrosisJosh J Carlson
Institute for Public Health Genetics, School of Public Health and Community Medicine, University of Washington, Washington 98195, USA
J Gastroenterol Hepatol 24:786-91. 2009..To assess the clinical and economic outcomes of non-invasive testing strategies in the diagnosis of significant liver fibrosis (Metavir score >or= 2) compared with liver biopsy...
BMI trajectories among the severely obese: results from an electronic medical record populationEdwin S Wong
Pharmaceutical Outcomes Research and Policy Program, University of Washington, Seattle, Washington, USA
Obesity (Silver Spring) 20:2107-12. 2012..Our results also suggest that once the 35 BMI threshold is reached, individuals will continue to remain severely obese, especially at younger ages...
Cost-effectiveness of primary versus secondary prophylaxis with pegfilgrastim in women with early-stage breast cancer receiving chemotherapyScott D Ramsey
Public Health Sciences Division, Fred Hutchinson Cancer Research Center and University of Washington Department of Medicine, Seattle, WA 98109, USA
Value Health 12:217-25. 2009....
Electronic prescribing at the point of care: a time-motion study in the primary care settingEmily Beth Devine
Biomedical and Health Informatics, School of Medicine, University of Washington, Seattle, WA
Health Serv Res 45:152-71. 2010..Two primary aims were to compare prescribing time between (1) handwritten and electronic (e-) prescriptions and (2) e-prescriptions using differing hardware configurations...
Community blood supply model: development of a new model to assess the safety, sufficiency, and cost of the blood supplyBrian Custer
Pharmaceutical Outcomes Research and Policy Program, University of Washington, Seattle, USA
Med Decis Making 25:571-82. 2005..However, as a result of increasingly stringent screening measures, one of the greatest threats may be an insufficient supply. The balance between safety and adequacy of the blood supply has not received enough attention...
The cost-effectiveness of the management of acute sinusitisYoshimi Anzai
Department of Radiology, University of Washington, Seattle 98195 7115, USA
Am J Rhinol 21:444-51. 2007..Sinusitis is a common medical disease with a tremendous economic impact on health care. Our objective was to determine the most cost-effective strategy for the management of acute sinusitis from the societal and payers' perspectives...
The economics of venous thromboembolism prophylaxis: a primer for cliniciansBruce L Davidson
Pulmonary and Critical Care Medicine Division, Swedish Medical Center and University of Washington School of Medicine, 801 Broadway, Suite 915, Seattle, WA 98122, USA
Chest 124:393S-396S. 2003..It is possible to list the important safety and efficacy outcomes of prophylaxis, estimate their incidences and costs, and "model" comparisons of one modality vs another, in order to help decide whether one is preferable...
Quality of life in adolescents with mild asthmaTeal S Hallstrand
Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of Washington, Seattle, Washington 98195 6522, USA
Pediatr Pulmonol 36:536-43. 2003..Symptoms of dyspnea during exercise are common in asthma and are associated with lower HRQoL. The clinical significance of these differences in HRQoL is unclear...
The use, safety and cost of bariatric surgery before and after Medicare's national coverage decisionDavid R Flum
University of Washington Schools of Medicine, Pharmacy and Public Health, Seattle, WA, USA
Ann Surg 254:860-5. 2011..To determine the impact of the Centers for Medicare and Medicaid Services' (CMS) bariatric surgery national coverage decision (NCD) on the use, safety, and cost of care CMS beneficiaries...
Colony-stimulating factor use and impact on febrile neutropenia among patients with newly diagnosed breast, colorectal, or non-small cell lung cancer who were receiving chemotherapyJeannine S McCune
Department of Pharmacy, University of Washington, Seattle, USA
Pharmacotherapy 32:7-19. 2012....
Conventional radiography, rapid MR imaging, and conventional MR imaging for low back pain: activity-based costs and reimbursementDarryl T Gray
Department of Pediatrics, School of Medicine, University of Washington, 146 N Canal St, Suite 300, Seattle, WA 98103, USA
Radiology 227:669-80. 2003..To incorporate personnel and equipment use time in an activity-based cost comparison of conventional radiography and conventional and rapid magnetic resonance (MR) imaging for low back pain (LBP)...
Rapid magnetic resonance imaging vs radiographs for patients with low back pain: a randomized controlled trialJeffrey G Jarvik
Department of Radiology, University of Washington, Seattle, Wash 98195, USA
JAMA 289:2810-8. 2003....
Randomized trial of pharmacist interventions to improve depression care and outcomes in primary careKam L Capoccia
Departments of Pharmacy and Family Medicine, University of Washington, Seattle, USA
Am J Health Syst Pharm 61:364-72. 2004..CONCLUSION: Frequent telephone contacts and interventions by pharmacists and UC in a primary care setting resulted in similar rates of adherence to antidepressant regimens and improvements in the outcomes of depression at one year...
Health care use and primary prophylaxis with colony-stimulating factorsSean D Sullivan
Fred Hutchinson Cancer Research Center, Seattle, WA 98109 1024, USA
Value Health 14:247-52. 2011..We examined health care use in conjunction with primary prophylaxis use of colony stimulating factors (CSF) during patients' initial course of chemotherapy...
Examining the BMI-mortality relationship using fractional polynomialsEdwin S Wong
Pharmaceutical Outcomes Research and Policy Program, University of Washington, Seattle, WA, USA
BMC Med Res Methodol 11:175. 2011..This approach was then compared against other commonly used regression models...
A forensic evaluation of the National Emphysema Treatment Trial using the expected value of information approachScott D Ramsey
Fred Hutchinson Cancer Research Center, University of Washington, Seattle, Washington 98109, USA
Med Care 46:542-8. 2008....
Expenditures and health status among adults with back and neck problemsBrook I Martin
Department of Orthopaedics and Sports Medicine, University of Washington, Seattle, WA 98104, USA
JAMA 299:656-64. 2008..Back and neck problems are among the symptoms most commonly encountered in clinical practice. However, few studies have examined national trends in expenditures for back and neck problems or related these trends to health status measures...
Toward evidence-based assessment for coverage and reimbursement of laboratory-based diagnostic and genetic testsScott D Ramsey
Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA
Am J Manag Care 12:197-202. 2006....
Cardiovascular events associated with ipratropium bromide in COPDSarika S Ogale
Pharmaceutical Outcomes Research and Policy Program, Department of Pharmacy, University of Washington, Seattle, WA, USA
Chest 137:13-9. 2010..We sought to examine the association between ipratropium bromide use and the risk of cardiovascular events (CVEs)...
The impact of e-prescribing on prescriber and staff time in ambulatory care clinics: a time motion studyWilliam Hollingworth
Department of Radiology, University of Washington, 325 Ninth Avenue, Seattle, WA 98104 2499, USA
J Am Med Inform Assoc 14:722-30. 2007..4 minutes/hour; 0.0, 10.7 CI). E-prescribing was not associated with an increase in combined computer and writing time for prescribers. If carefully implemented, e-prescribing will not greatly disrupt workflow...
The impact of computerized provider order entry on medication errors in a multispecialty group practiceEmily Beth Devine
Pharmaceutical Outcomes Research and Policy Program, School of Pharmacy, University of Washington, Seattle, Washington 98195 7630, USA
J Am Med Inform Assoc 17:78-84. 2010..The objective was to evaluate the effect of a basic, ambulatory CPOE system on medication errors and associated ADEs...
Comparison of guideline-based control definitions and associations with outcomes in severe or difficult-to-treat asthmaJonathan D Campbell
Pharmaceutical Outcomes Research and Policy Program, University of Washington, Seattle, Washington 98195, USA
Ann Allergy Asthma Immunol 101:474-81. 2008..The National Asthma Education and Prevention Program put forth guidance on how to measure asthma control. This guidance is flexible regarding how the impairment component of control is assessed...
Cost-effectiveness and population outcomes of general population screening for hepatitis CPhillip O Coffin
Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, WA 98104, USA
Clin Infect Dis 54:1259-71. 2012..Current US guidelines recommend limiting hepatitis C virus (HCV) screening to high-risk individuals, and 50%-75% of infected persons remain unaware of their status...
Treatment success for overactive bladder with urinary urge incontinence refractory to oral antimuscarinics: a review of published evidenceJonathan D Campbell
School of Pharmacy, University of Washington, Seattle, USA
BMC Urol 9:18. 2009..Our objective was to conduct a literature review and synthesis of published measures of treatment success for OAB with UUI interventions and to identify a treatment success outcome...
Updated evaluation of the cost-effectiveness of lung volume reduction surgeryScott D Ramsey
Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, M3 B232, Seattle, WA 98109, USA
Chest 131:823-32. 2007..We present an updated analysis of cost-effectiveness with 1-year additional follow-up data...
Cost-effectiveness of lung volume reduction surgeryScott D Ramsey
Cancer Prevention Program, Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA
Proc Am Thorac Soc 5:406-11. 2008....
A guideline for the use of pharmacoeconomic models of diabetes treatment in the US managed-care environmentDavid L Veenstra
Pharmaceutical Outcomes Research and Policy Program, University of Washington, Seattle, Washington, USA
Pharmacoeconomics 20:21-30. 2002....
Resource costs for asthma-related care among pediatric patients in managed careKarna Gendo
School of Pharmacy, University of Washington, Seattle, Washington, USA
Ann Allergy Asthma Immunol 91:251-7. 2003..Understanding the relationship between total costs of asthma-related care and morbidity can assist in designing the most cost-effective asthma care strategies to improve patient outcomes and minimize total costs...
Cost effectiveness of lung-volume-reduction surgery for patients with severe emphysemaScott D Ramsey
Fred Hutchinson Cancer Research Center, Public Health Sciences Division, Seattle, WA 98109, USA
N Engl J Med 348:2092-102. 2003..The National Emphysema Treatment Trial, a randomized clinical trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema, included a prospective economic analysis...
Cost-effectiveness of combination peginterferon alpha-2a and ribavirin compared with interferon alpha-2b and ribavirin in patients with chronic hepatitis CS D Sullivan
University of Washington, Seattle WA 98195, USA
Am J Gastroenterol 99:1490-6. 2004....
An economic evaluation of atorvastatin for primary prevention of cardiovascular events in type 2 diabetesScott D Ramsey
Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USAUniversity of Washington, Seattle, WA 98109, USA
Pharmacoeconomics 26:329-39. 2008..We estimated the cost effectiveness of atorvastatin as primary prevention against CV disease from the short-term and lifetime US payer perspectives...
Cost-effectiveness analysis of laparoscopic gastric bypass, adjustable gastric banding, and nonoperative weight loss interventionsLeon Salem
Department of Surgery, University of Washington School of Medicine, Seattle, Washington 98195 6410, USA
Surg Obes Relat Dis 4:26-32. 2008..We designed a model to evaluate the incremental cost-effectiveness of these procedures compared with nonoperative weight loss interventions and with each other...
Cost-effectiveness analysis of early intervention with budesonide in mild persistent asthmaSean D Sullivan
Department of Pharmacy and Health Services, University of Washington, Seattle, Washington 98195-7630, USA
J Allergy Clin Immunol 112:1229-36. 2003..10-US dollars 8.00). Early intervention was more effective and cost saving in the youngest age group. CONCLUSION: Long-term treatment with budesonide appears to be cost-effective in patients with mild persistent asthma of recent onset...
CDR state transition probabilities in Alzheimer's disease with and without cholinesterase inhibitor intervention in an observational cohortLisa M Bloudek
Pharmaceutical Outcomes Research and Policy Program, University of Washington, Seattle, WA 98195 7630, USA
J Alzheimers Dis 24:599-607. 2011..The NACC-UDS dataset is ongoing and this analysis may be improved if repeated when more data is available...
The timing of elective colectomy in diverticulitis: a decision analysisLeon Salem
Department of Surgery, University of Washington, Seattle, WA 98195-6410, USA
J Am Coll Surg 199:904-12. 2004..CONCLUSIONS: This study suggests that expectant management is associated with lower rates of death and colostomy and is cost-saving for both younger and older patients...
The impact of using different imputation methods for missing quality of life scores on the estimation of the cost-effectiveness of lung-volume-reduction surgeryDavid K Blough
Pharmaceutical Outcomes Research and Policy Program, University of Washington, Seattle, WA, USA
Health Econ 18:91-101. 2009..Owing to the effects of different imputation methods for missing quality of life data on the estimation of the ICER, we recommend use of a minimum of two imputation methods that always include multiple imputation...
Economic costs of nonmedical use of prescription opioidsRyan N Hansen
Department of Pharmacy, Pharmaceutical Outcomes Research and Policy Program, University of Washington, Seattle, Washington, USA
Clin J Pain 27:194-202. 2011....
A Bayesian approach to aid in formulary decision making: incorporating institution-specific cost-effectiveness data with clinical trial resultsShelby D Reed
Pharmaceutical Outcomes Research and Policy Program, University of Washington, USA
Med Decis Making 23:252-64. 2003..Among patients undergoing coronary stenting, the cost-effectiveness ratio of the addition of abciximab was at or below the $50,000 per life year saved threshold in 66.0% of the simulations...
The cost-effectiveness of an inner-city asthma intervention for childrenSean D Sullivan
Departments of Pharmacy and Health Services, Box 357630, University of Washington, Seattle, WA 98195, USA
J Allergy Clin Immunol 110:576-81. 2002..Organizations serving this population should consider this strategy as part of a comprehensive disease-management program for asthma...
Prescriber and staff perceptions of an electronic prescribing system in primary care: a qualitative assessmentEmily Beth Devine
Pharmaceutical Outcomes Research and Policy Program, University of Washington, Seattle, WA 98195 7630, USA
BMC Med Inform Decis Mak 10:72. 2010..We describe prescriber and staff perceptions of implementation of a CPOE system for medications (electronic- or e-prescribing system) in the ambulatory setting...
Chronic obstructive pulmonary disease: is there a case for early intervention?Scott D Ramsey
Fred Hutchinson Cancer Research Center, Seattle, Washington 98109, USA
Am J Med 117:3S-10S. 2004..The economic value of aggressive pharmacotherapy for early-stage COPD is less certain, but the burden of illness and potential pharmacoeconomic benefits in such patients is a strong rationale for combined clinical and economic trials...
Characterization of prescribing errors in an internal medicine clinicEmily Beth Devine
Department of Pharmacy, University of Washington UW, Seattle, WA 98195 7630, USA
Am J Health Syst Pharm 64:1062-70. 2007....
Trends and geographic variation of opiate medication use in state Medicaid fee-for-service programs, 1996 to 2002Judy T Zerzan
HSR and D Department of Veterans Affairs, Puget Sound Health Care System, Seattle, WA 98101, USA
Med Care 44:1005-10. 2006..This study describes temporal and interstate variability in aggregate prescription opiate medication use within U.S. Medicaid programs...
Cost analysis of interventions for antimuscarinic refractory patients with overactive bladderJonathan H Watanabe
Pharmaceutical Outcomes Research and Policy Program, University of Washington, Seattle, Washington, USA
Urology 76:835-40. 2010....
Colony-stimulating factor prescribing patterns in patients receiving chemotherapy for cancerScott D Ramsey
Fred Hutchinson Cancer Research Center, Seattle, WA 98109 1024, USA
Am J Manag Care 16:678-86. 2010..To examine variables influencing colony-stimulating factor (CSF) prescription as primary prophylaxis versus other use during patients' initial chemotherapy course among a large sample of health insurance records...
Improving pediatric asthma outcomes in the community setting: does pharmaceutical care make a difference?Andy Stergachis
Department of Pharmacy, University of Washington, Seattle 98105, USA
J Am Pharm Assoc (Wash) 42:743-52. 2002..To assess the effect of a structured program of pharmaceutical care on changes in disease control, functional status, and health services utilization for pediatric and adolescent patients with moderate-to-severe asthma...
More isn't always better: cost-effectiveness analysis and the case for using a split-night protocolVishesh K Kapur
Department of Medicine, University of Washington, Seattle, WA, USA
J Clin Sleep Med 2:154-5. 2006
Effectiveness of screening examinations to detect unrecognized exercise-induced bronchoconstrictionTeal S Hallstrand
Division of Pulmonary and Critical Care Medicine, Department of Medicine, The School of Public Health and Community Medicine, University of Washington, Seattle 98195, USA
J Pediatr 141:343-8. 2002..8% of the adolescents with EIB. CONCLUSIONS: EIB occurs frequently in adolescent athletes, and screening by physical examination and medical history does not accurately detect it...
Collaborative care model to improve outcomes in major depressionDenise M Boudreau
Department of Pharmacy, University of Washington, Seattle, WA 98195 7630, USA
Ann Pharmacother 36:585-91. 2002..To develop a pharmacist intervention to improve depression care and outcomes within a primary care setting...
Rapid magnetic resonance imaging for diagnosing cancer-related low back painWilliam Hollingworth
Departments of Radiology, University of Washington, Seattle, Wash 98103, USA
J Gen Intern Med 18:303-12. 2003..This study compared the relative efficiency of lumbar x-ray and rapid magnetic resonance (MR) imaging for diagnosing cancer-related low back pain (LBP) in primary care patients...
Development of a quantifiable symptom assessment tool for patients with chronic bronchitis: the Chronic Bronchitis Symptoms Assessment ScaleDavid H Au
Health Services Research and Development, VA Puget Sound Health Care System, 1660 S Columbian Way, Seattle, Washington 98108, USA
COPD 2:209-16. 2005..67) and SOBQ (r = 0.50). The Chronic Bronchitis Symptoms Assessment Scale is an easy to administer, once daily or once weekly, valid and reliable outcome measure for assessing symptom severity among patients with chronic bronchitis...
Health care utilization and cost among adults with chronic rhinosinusitis enrolled in a health maintenance organizationMichael P Murphy
Center for Health Studies, Group Health Cooperative of Puget Sound, Seattle, Washington, USA
Otolaryngol Head Neck Surg 127:367-76. 2002..CONCLUSIONS: Adults with CRS had higher costs primarily because of increased nonurgent outpatient visit and pharmacy fill utilization. The overall direct cost of CRS in the United States in 1994 is estimated to have been $4.3 billion...
Modeling the cost and outcomes of pharmacist-prescribed emergency contraceptionK D Marciante
Department of Pharmacy, University of Washington, Seattle, 98195, USA
Am J Public Health 91:1443-5. 2001..This study investigated the effect on the risk and cost of unintended pregnancies of emergency contraceptive pills obtained directly from a pharmacist...
The response to combination therapy treatment regimens in severe/difficult-to-treat asthmaJ D Campbell
Pharmaceutical Outcomes Research and Policy Program, University of Washington, 1959 NE Pacific Ave, H375Q, Box 357630, Seattle, WA 98195, USA
Eur Respir J 32:1237-42. 2008..While additional studies are needed, the present findings call for alternative therapeutic approaches in severe/difficult-to-treat asthma for those unable to attain asthma control with or without salmeterol/fluticasone combination...
The cost of treating ribavirin-induced anemia in hepatitis C: the impact of using recombinant human erythropoietinE B Devine
University of Washington Department of Pharmacy, Seattle, WA 98195 7630, USA
Curr Med Res Opin 23:1463-72. 2007..The secondary objective was to calculate the incremental cost of using epoetin versus no epoetin to treat RIA, per ribavirin dose reduction/discontinuation averted...
Cost and cost-effectiveness of universal screening for hearing loss in newbornsE J Kezirian
Department of Otolaryngology Head and Neck Surgery, University of Washington, Seattle, 98195, USA
Otolaryngol Head Neck Surg 124:359-67. 2001..To estimate the cost and cost-effectiveness of universal newborn hearing screening...
Economic evaluation of systemic treatments for cytomegalovirus retinitis in patients with AIDST A Lee
Pharmaceutical Outcomes Research and Policy Program, University of Washington, Seattle 98195, USA
Pharmacoeconomics 19:535-50. 2001..To determine the cost of using systemic therapy to treat newly diagnosed cytomegalovirus (CMV) retinitis in persons with AIDS...
Management strategies for ribavirin-induced hemolytic anemia in the treatment of hepatitis C: clinical and economic implicationsE B Devine
University of Washington, Department of Pharmacy, Box 357630, Seattle, WA 98195 7630, USA
Value Health 4:376-84. 2001..The objective of this study was to evaluate the direct health-care costs and management of RIHA during treatment of CHC in a clinical trial setting...
The costs of treating COPD in the United StatesS A Strassels
Department of Pharmacy, University of Washington, Seattle, WA 98195, USA
Chest 119:344-52. 2001..COPD affects millions of people in the United States. The purpose of this study was to describe the medical resource use and costs incurred by persons with COPD in the United States in 1987...
The economics of treatment for infants with respiratory distress syndromeN Neil
Department of Pharmacy, University of Washington, Seattle 98195 8773, USA
Med Decis Making 18:44-51. 1998....
Cost-effectiveness of antiseptic-impregnated central venous catheters for the prevention of catheter-related bloodstream infectionD L Veenstra
Pharmaceutical Outcomes Research and Policy Program and Department of Pharmacy, University of Washington, Seattle 98195 7630, USA
JAMA 282:554-60. 1999....
Efficacy of antiseptic-impregnated central venous catheters in preventing catheter-related bloodstream infection: a meta-analysisD L Veenstra
Department of Pharmacy, University of Washington, Seattle, USA
JAMA 281:261-7. 1999..However, there remains some uncertainty regarding the efficacy of these catheters because of conflicting reports in the literature...
Global epidemiology of hepatitis B virusBrian Custer
Pharmaceutical Outcomes Research and Policy Program, University of Washington, Seattle, WA, USA
J Clin Gastroenterol 38:S158-68. 2004..Preventing the most severe HBV disease consequences in infected individuals, such as cirrhosis and hepatocellular carcinoma, will require appropriate therapeutic agents...
Linking payment to health outcomes: a taxonomy and examination of performance-based reimbursement schemes between healthcare payers and manufacturersJosh J Carlson
Pharmaceutical Outcomes Research and Policy Program, University of Washington, 1959 NE Pacific Street, Seattle, WA 98195 7630, United States
Health Policy 96:179-90. 2010..To identify, categorize and examine performance-based health outcomes reimbursement schemes for medical technology...
Global management guidelines and quality of care indicators for asthma and COPDSean D Sullivan
Pharmaceutical Outcomes Research and Policy Program, University of Washington, Seattle, WA, USA
Manag Care 14:16-9; discussion 24-6. 2005
States' control of prescription drug spending: a heterogeneous approachNancy E Morden
University of Washington, in Seattle, USA
Health Aff (Millwood) 24:1032-8. 2005....
The burden of uncontrolled asthma on the U.S. health care systemSean D Sullivan
School of Pharmacy and Public Health, University of Washington, Seattle, USA
Manag Care 14:4-7; discussion 25-7. 2005
The burden of illness and economic evaluation for COPDS D Ramsey
Fred Hutchinson Cancer Research Center, Dept of Pharmacy, University of Washington, Seattle, WA 98109, USA
Eur Respir J Suppl 41:29s-35s. 2003....
On the use of survival analysis techniques to estimate medical care costsR D Etzioni
Fred Hutchinson Cancer Research Center, Seattle, WA 98109 1024, USA
J Health Econ 18:365-80. 1999..Our observations are confirmed through simulations and empirical data analysis. We conclude that survival analysis approaches are not generally appropriate for the analysis of medical costs and review several valid alternatives...
Consensus guidelines for specialty pharmaceuticals: a best-practice approach for cost-effective managementSean D Sullivan
School of Pharmacy, University of Washington, Seattle, USA
Am J Manag Care 10:S242-4; discussion 245-51. 2004
Design and analytic considerations in determining the cost-effectiveness of early intervention in asthma from a multinational clinical trialS D Sullivan
Departments of Pharmacy and Health Services, University of Washington, Seattle, WA, USA
Control Clin Trials 22:420-37. 2001..This paper will present and discuss several methodological options and the current state of the art for conducting economic evaluations alongside multinational clinical trials...
Managing biotechnology in a network-model health plan: a U.S. private payer perspectiveJohn B Watkins
Premera Blue Cross in Mountlake Terrace, Washington, USA
Health Aff (Millwood) 25:1347-52. 2006..Creative approaches to provider reimbursement can align providers' incentives with those of the plan. Redesign of member benefits can also encourage appropriate use of biotechnology...
Extent, patterns, and burden of uncontrolled disease in severe or difficult-to-treat asthmaS D Sullivan
Pharmaceutical Outcomes Research and Policy Program, University of Washington, Seattle, WA 98195, USA
Allergy 62:126-33. 2007..The objective was to characterize and compare the economic burden of severe or difficult-to-treat asthma in uncontrolled and controlled patients...
Association of control and risk of severe asthma-related events in severe or difficult-to-treat asthma patientsS D Sullivan
Pharmaceutical Outcomes Research and Policy Program, Department of Pharmacy, University of Washington, Seattle, WA, USA
Allergy 62:655-60. 2007..This study investigated the association of asthma control and subsequent severe asthma-related healthcare events in The Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimens (TENOR) study...
Showing outcomes and proving value brings successD S Fullerton
Pharmacy Services, Regence BlueShield, Seattle, USA
Manag Care Interface 14:63-5, 71. 2001..In 1998, Regence adopted formulary submission guidelines that have proven a solid success, and have been adopted by the Academy of Managed Care Pharmacy, Alexandria, Virginia, for evaluation nationwide...
Design issues for conducting cost-effectiveness analyses alongside clinical trialsS D Ramsey
Department of Medicine, University of Washington, Seattle, Washington 98195, USA
Annu Rev Public Health 22:129-41. 2001..Many potential threats to external validity can be successfully addressed if they are identified and accounted for in the design phase of the study...
Economic analysis of lung volume reduction surgery as part of the National Emphysema Treatment Trial. NETT Research GroupS D Ramsey
Department of Medicine, University of Washington, Seattle, USA
Ann Thorac Surg 71:995-1002. 2001....
The medical cost of undiagnosed sleep apneaV Kapur
Department of Medicine, University of Washington, Seattle 98195, USA
Sleep 22:749-55. 1999..4 billion in additional medical costs in the U.S. Whether medical cost savings occur with treatment of sleep apnea remains to be determined...
